Neurology

The treatment of mental illness has long been a quandary for medical professionals throughout history. But historically, mental illness has been more loosely defined than it is today.

Compared with patients with focal epilepsy, those with genialized epilepsy have a higher risk of obstructive sleep apnea.

A final vote that assessed whether the findings from the EMERGE trial served as primary evidence for the efficacy of aducanumab in Alzheimer disease was 10–0 that the trial did not provide evidence.

The current acute treatments for migraines have shown efficacy and safety, however, approximately one-third of people do not respond, cannot use these options due to contraindications, or report dissatisfaction in therapy.

Simple sugar found in breast milk and dietary supplements may promote myelin repair in patients with multiple sclerosis.

Approximately half of the people with multiple sclerosis (MS) have the HLA-DR15 gene variant, which is responsible for up to 60% of genetic risk.

Research has also shown that patients with Parkinson disease who are able to engage in physical activity can potentially improve the motor and non-motor symptoms associated with the disease.

Ubrogepant (Ubrelvy, Allergan) was approved for the treatment of acute migraines with or without aura in adults after showing a significantly greater reduction in headache pain compared with placebo.

VX-765, a novel multiple sclerosis drug, works by inhibiting a component of inflammasomes that promotes harmful inflammation.

Several risk factors for multiple sclerosis, such as disease progression and fatigue, increase the risk of unemployment.

Women who had longer reproductive periods during their lifetimes were found to have a greater risk of dementia in older age compared with those who had shorter reproductive periods.

Dimethyl fumarate is indicated to treat relapsing forms of multiple sclerosis in adult patients.

Integrating specialty pharmacy staff into oncology, neurology, rheumatology, and other specialty clinics within their health systems is a growing trend with a range of beneficial outcomes.

Individuals with asymptomatic Alzheimer disease are more likely to fall than those who are not on track to develop dementia.

Pregnancy may help put off the onset of multiple sclerosis symptoms by more than 3 years.

There were a number of FDA approvals in 2019 that were either the first new therapies or first in class approved for certain conditions, and the specialty pipeline is continuing to grow at a rapid pace.

In the face of the COVID-19 pandemic, neurologists are concerned that immunosuppressive treatments for multiple sclerosis and other disorders have significant risks.

An investigational drug for treating amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, has been shown to slow the progression of the disease.

There is a new study that discovered certain drugs cause problems in healthy people who do not have risk factors or family members with dementia.

Research suggests that those with progressive multiple sclerosis may have adjusted more effectively to lockdown conditions.

Although there is no underlying mechanism specifically associating cognitive and visual impairment, the investigators noted that the relationship between cognitive and visual function is likely bidirectional and multifactorial.

Post-menopausal women are at a heightened risk of Alzheimer disease.

Individuals with a higher risk of cardiovascular disease (CVD) demonstrate an increase in cognitive decline, including a rise in the typical markers of Alzheimer disease, according to the results of a recent study.

Flavonoids are natural substances found in plants, including fruits and vegetables, and are associated with various health benefits, such as reduced inflammation.

Contrary to previous studies, the rate of cognitive impairment has increased over the past 20 years.